NCT04544995 2026-01-21Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)GlaxoSmithKlinePhase 1 Terminated47 enrolled 43 charts
NCT01976741 2021-05-06Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)BayerPhase 1 Completed168 enrolled 59 charts
NCT01943864 2017-05-31A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract CancersGlaxoSmithKlinePhase 2 Completed20 enrolled 27 charts